{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:48:22Z","timestamp":1778028502465,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.clinph.2012.11.004","type":"journal-article","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T03:45:22Z","timestamp":1355370322000},"page":"999-1004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Botulinum neurotoxin serotype D is poorly effective in humans: An in vivo electrophysiological study"],"prefix":"10.1016","volume":"124","author":[{"given":"Roberto","family":"Eleopra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesare","family":"Montecucco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grazia","family":"Devigili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Lettieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Rinaldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Verriello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Pirazzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Caccin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ornella","family":"Rossetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinph.2012.11.004_b0005","series-title":"Handbook of toxicology of chemical warfare agents","first-page":"407","article-title":"Botulinum toxins","author":"Anderson","year":"2009"},{"issue":"Suppl. 1","key":"10.1016\/j.clinph.2012.11.004_b0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/PL00007816","article-title":"Pharmacology and immunology of botulinum toxin serotypes","volume":"248","author":"Aoki","year":"2001","journal-title":"J Neurol"},{"key":"10.1016\/j.clinph.2012.11.004_b0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/(SICI)1097-4547(19990101)55:1<119::AID-JNR13>3.0.CO;2-6","article-title":"Cardiotrophin-1 requires LIFR beta to promote survival of mouse motoneurons purified by a novel technique","volume":"55","author":"Arce","year":"1999","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.clinph.2012.11.004_b0020","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jmb.2006.07.040","article-title":"A structural perspective of the sequence variability within botulinumn eurotoxin subtypes A1\u2013A4","volume":"362","author":"Arndt","year":"2006","journal-title":"J Mol Biol"},{"key":"10.1016\/j.clinph.2012.11.004_b0025","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.410310619","article-title":"Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome","volume":"31","author":"Chiba","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clinph.2012.11.004_b0030","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1471-4159.1982.tb07959.x","article-title":"Myelin gangliosides in vertebrates","volume":"39","author":"Cochran","year":"1982","journal-title":"J Neurochem"},{"key":"10.1016\/j.clinph.2012.11.004_b0035","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0022-3565(24)36519-X","article-title":"In vitro characterization of botulinum toxin types A, C and D action on human tissues: combined electrophysiologic, pharmacologic and molecular biologic approaches","volume":"280","author":"Coffield","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.clinph.2012.11.004_b0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1468-1331.2006.01439.x","article-title":"Immunological aspects of Botox, Dysport and Myobloc\/NeuroBloc","volume":"13","author":"Dressler","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clinph.2012.11.004_b0045","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/mds.20625","article-title":"Mouse diaphragm assay for detection of antibodies against botulinum toxin type B","volume":"20","author":"Dressler","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.clinph.2012.11.004_b0050","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/mds.870120115","article-title":"The variability in the clinical effect induced by botulinum toxin type A: the role of muscle activity in humans","volume":"12","author":"Eleopra","year":"1997","journal-title":"Mov Disord"},{"key":"10.1016\/j.clinph.2012.11.004_b0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3940(97)13448-6","article-title":"Botulinum neurotoxin serotype C: a novel effective botulinum toxin therapy in human","volume":"224","author":"Eleopra","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.clinph.2012.11.004_b0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0304-3940(98)00775-7","article-title":"Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans","volume":"256","author":"Eleopra","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.clinph.2012.11.004_b0055","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S1388-2457(02)00103-7","article-title":"Botulinum neurotoxin serotypes A and C do not affect motor units survival in humans: an electrophysiological study by motor units counting","volume":"113","author":"Eleopra","year":"2002","journal-title":"Clin Neurophysiol"},{"issue":"Suppl. 8","key":"10.1016\/j.clinph.2012.11.004_b0060","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1002\/mds.20010","article-title":"Different types of botulinum toxin in humans","volume":"19","author":"Eleopra","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.clinph.2012.11.004_b0075","doi-asserted-by":"crossref","first-page":"11061","DOI":"10.1016\/S0021-9258(18)60426-0","article-title":"Two vesicle-associated membrane protein genes are differentially expressed in the rat central nervous system","volume":"264","author":"Elferink","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinph.2012.11.004_b0080","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/mr.46.1.86-94.1982","article-title":"Bacterial toxins: a table of lethal amounts","volume":"46","author":"Gill","year":"1982","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.clinph.2012.11.004_b0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/1531-8249(200007)48:1<7::AID-ANA2>3.0.CO;2-O","article-title":"How does botulinum toxin work?","volume":"48","author":"Hallett","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clinph.2012.11.004_b0090","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/brain\/awh231","article-title":"Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy","volume":"127","author":"Halstead","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.clinph.2012.11.004_b0095","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1460-9568.1998.00050.x","article-title":"VAMP-1 and VAMP-2 gene expression in rat spinal motoneurons: differential regulation after neuronal injury","volume":"10","author":"Jacobsson","year":"1998","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.clinph.2012.11.004_b0100","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/jnnp.2003.034702","article-title":"Botulinum toxin in clinical practice","volume":"75","author":"Jankovic","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clinph.2012.11.004_b0105","series-title":"Neuromuscular junction disorders. Handbook of clinical neurology","first-page":"333","article-title":"Neuromuscular junction disorders","author":"Johnson","year":"2008"},{"key":"10.1016\/j.clinph.2012.11.004_b0110","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00216-012-5767-3","article-title":"De novo subtype and strain identification of botulinum neurotoxin type B through toxin proteomics","volume":"403","author":"Kalb","year":"2012","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.clinph.2012.11.004_b0115","doi-asserted-by":"crossref","first-page":"8117","DOI":"10.1021\/bi100865f","article-title":"Identification of a unique ganglioside binding loop within botulinum neurotoxins C and D-SA","volume":"49","author":"Karalewitz","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.clinph.2012.11.004_b0120","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jmb.2008.12.027","article-title":"Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation","volume":"386","author":"Kumaran","year":"2009","journal-title":"J Mol Biol"},{"key":"10.1016\/j.clinph.2012.11.004_b0125","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1006\/jmbi.1999.2945","article-title":"Sequence homology and structural analysis of the clostridial neurotoxins","volume":"291","author":"Lacy","year":"1999","journal-title":"J Mol Biol"},{"key":"10.1016\/j.clinph.2012.11.004_b0130","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1126\/science.130.3378.763","article-title":"The most poisonous poison","volume":"130","author":"Lamanna","year":"1959","journal-title":"Science"},{"issue":"Suppl. 4","key":"10.1016\/j.clinph.2012.11.004_b0135","first-page":"331","article-title":"Neurobiology of gangliosides","volume":"9","author":"Ledeen","year":"1986","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.clinph.2012.11.004_b0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1523\/JNEUROSCI.4017-06.2007","article-title":"Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model","volume":"27","author":"Lehmann","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.clinph.2012.11.004_b0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0006-8993(84)90737-6","article-title":"Autoradiographic localization and depolarization-induced release of acidic amino acids in differentiating cerebellar granule cell cultures","volume":"290","author":"Levi","year":"1984","journal-title":"Brain Res"},{"key":"10.1016\/j.clinph.2012.11.004_b0150","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1523\/JNEUROSCI.16-01-00137.1996","article-title":"Axonal transport and distribution of synaptobrevin I and II in the rat peripheral nervous system","volume":"16","author":"Li","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.clinph.2012.11.004_b0155","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1113\/jphysiol.1989.sp017568","article-title":"A study of synchronization of quantal transmitter release from mammalian motor endings by the use of botulinal toxins type A and D","volume":"411","author":"Molg\u00f3","year":"1989","journal-title":"J Physiol"},{"key":"10.1016\/j.clinph.2012.11.004_b0160","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1146\/annurev.biochem.051908.125345","article-title":"Botulinum neurotoxin: a marvel of protein design","volume":"79","author":"Montal","year":"2010","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.clinph.2012.11.004_b0165","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.coph.2004.12.006","article-title":"Botulinal neurotoxins: revival of an old killer","volume":"5","author":"Montecucco","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.clinph.2012.11.004_b0175","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1017\/S0033583500003292","article-title":"Structure and function of tetanus and botulinum neurotoxins","volume":"28","author":"Montecucco","year":"1995","journal-title":"Quart Rev Biophys"},{"key":"10.1016\/j.clinph.2012.11.004_b0170","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0014-5793(94)00449-8","article-title":"Bacterial protein toxins penetrate cells via a four-step mechanism","volume":"346","author":"Montecucco","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/j.clinph.2012.11.004_b0180","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/aem.62.2.662-667.1996","article-title":"Molecular cloning of the gene encoding the mosaic neurotoxin, composed of parts of botulinum neurotoxin types C1 and D, and PCR detection of this gene from Clostridium botulinum type C organisms","volume":"62","author":"Moriishi","year":"1996","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.clinph.2012.11.004_b0185","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1128\/IAI.00302-12","article-title":"Unique biological activity of botulinum D\/C mosaic neurotoxin in murine species","volume":"80","author":"Nakamura","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.clinph.2012.11.004_b0190","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/0140-6736(90)93157-K","article-title":"Infant botulism due to Clostridium botulinum type C toxin","volume":"336","author":"Oguma","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.clinph.2012.11.004_b0195","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/364581b0","article-title":"Neurotransmission and secretion","volume":"364","author":"Patarnello","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.clinph.2012.11.004_b0200","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0031-6997(25)06991-1","article-title":"The neurotoxins of Clostridium botulinum and Clostridium tetani","volume":"7","author":"Payling-Wright","year":"1955","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.clinph.2012.11.004_b0205","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1006\/taap.1994.1181","article-title":"Measurement of botulinum toxin activity: evaluation of the lethality assay","volume":"128","author":"Pearce","year":"1994","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.clinph.2012.11.004_b0210","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0378-4274(98)00306-3","article-title":"In vitro biological activity and toxicity of tetanus and botulinum neurotoxins","volume":"102\u2013103","author":"Pellizzari","year":"1998","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.clinph.2012.11.004_b0215","doi-asserted-by":"crossref","first-page":"e1002008","DOI":"10.1371\/journal.ppat.1002008","article-title":"Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors","volume":"7","author":"Peng","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.clinph.2012.11.004_b0220","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1111\/j.1462-5822.2011.01654.x","article-title":"Double anchorage to the membrane and intact inter-chain disulfide bond are required for the low pH induced entry of tetanus and botulinum neurotoxins into neurons","volume":"13","author":"Pirazzini","year":"2011","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.clinph.2012.11.004_b0225","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.toxicon.2009.01.019","article-title":"Measurement of botulinum types A, B and E neurotoxicity using the phrenic nerve-hemidiaphragm: improved precision with in-bred mice","volume":"53","author":"Rasetti-Escargueil","year":"2009","journal-title":"Toxicon"},{"key":"10.1016\/j.clinph.2012.11.004_b0230","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1242\/jcs.01218","article-title":"Snake presynaptic neurotoxins with phospholipase A2 activity induce punctate swellings of neurites and exocytosis of synaptic vesicles","volume":"117","author":"Rigoni","year":"2004","journal-title":"J Cell Sci"},{"issue":"Suppl. 1","key":"10.1016\/j.clinph.2012.11.004_b0235","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1468-1331.2006.01438.x","article-title":"Pharmacology of botulinum toxin: differences between type A preparations","volume":"13","author":"Rosales","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.clinph.2012.11.004_b0240","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1471-4159.2006.03965.x","article-title":"Presynaptic enzymatic neurotoxins","volume":"97","author":"Rossetto","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.clinph.2012.11.004_b0255","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0076-6879(95)48041-2","article-title":"Tetanus and botulism neurotoxins: isolation and assay","volume":"248","author":"Schiavo","year":"1995","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.clinph.2012.11.004_b0250","doi-asserted-by":"crossref","first-page":"23784","DOI":"10.1016\/S0021-9258(20)80452-9","article-title":"Identification of the nerve-terminal targets of botulinum neurotoxins serotype A, D and E","volume":"268","author":"Schiavo","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinph.2012.11.004_b0245","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1749-6632.1994.tb26614.x","article-title":"Tetanus and botulinum neurotoxins are zinc proteases specific for components of the neuroexocytosis apparatus","volume":"710","author":"Schiavo","year":"1994","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.clinph.2012.11.004_b0260","first-page":"143","article-title":"Growth of clostridia and preparation of their neurotoxins","volume":"195","author":"Shone","year":"1995","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.clinph.2012.11.004_b0265","series-title":"Botulism: the organism, its toxins, the disease","author":"Smith","year":"1988"},{"key":"10.1016\/j.clinph.2012.11.004_b0275","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1042\/BJ20101042","article-title":"Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner","volume":"431","author":"Strotmeier","year":"2010","journal-title":"Biochem J"},{"key":"10.1016\/j.clinph.2012.11.004_b0270","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2958.2011.07682.x","article-title":"The biological activity of botulinum neurotoxin type C is dependent upon novel types of ganglioside binding sites","volume":"81","author":"Strotmeier","year":"2011","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.clinph.2012.11.004_b0280","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1021\/bi3004928","article-title":"Botulinum neurotoxins B and E translocate at different rates and exhibit divergent responses to GT1b and low pH","volume":"51","author":"Sun","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.clinph.2012.11.004_b0285","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/78005","article-title":"Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B","volume":"7","author":"Swaminathan","year":"2000","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.clinph.2012.11.004_b0290","unstructured":"Wiegandt H. Glycolipids. Elsevier, vol. 10; 1985."},{"key":"10.1016\/j.clinph.2012.11.004_b0300","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"Willison","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.clinph.2012.11.004_b0295","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1212\/WNL.44.12.2395","article-title":"Acute ataxic neuropathy with cross-reactive antibodies to GD1b and GD3 gangliosides","volume":"44","author":"Willison","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.clinph.2012.11.004_b0305","doi-asserted-by":"crossref","first-page":"12764","DOI":"10.1016\/S0021-9258(18)99941-2","article-title":"Cleavage of members of the synaptobrevin\/VAMP family by types D and F botulinal neurotoxins and tetanus toxin","volume":"269","author":"Yamasaki","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinph.2012.11.004_b0310","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.bbrc.2010.11.134","article-title":"Crystal structure of the receptor binding domain of the botulinum C\u2013D mosaic neurotoxin reveals potential roles of lysines 1118 and 1136 in membrane interactions","volume":"404","author":"Zhang","year":"2011","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138824571200733X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138824571200733X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:11:39Z","timestamp":1761390699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138824571200733X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S138824571200733X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinph.2012.11.004","relation":{},"ISSN":["1388-2457"],"issn-type":[{"value":"1388-2457","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum neurotoxin serotype D is poorly effective in humans: An in vivo electrophysiological study","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinph.2012.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}